NLHEP has as its theme: "Test Your Lungs - Know Your Numbers". Measures of air flow and volume are indicators of lung health and these noninvasive tests can be done in the physician's office with a spirometer, a device used to measure lung health.
Shown here is a simple handheld spirometer that can be used either in, or away from, the physician's office. Blowing forcefully into the tube provides a quick, easy measure of both FEV1 and FEV6 (FVC).
To learn your FEV1 and FEV6, you will be asked to hold the tube of a spirometer in your mouth, inhale as much air as possible, then exhale forcefully into the spirometer for six seconds or more.
The FEV6 is an excellent surrogate for FVC. Thus, doing a six-second expiratory maneuver is more pleasant for the patient and more convenient for the tester.
Most available spirometers use the two parameters: FEV1 and FVC (or FEV6). Predicted values for FEV1, FEV6, and FVC have been validated and published. Your measured values can be compared to the predicted values to determine if you have airway obstruction, and if so, how severe the obstruction may be. You may also be asked to inhale a bronchodilator and repeat the spirometry measurements to assess whether your airway obstruction is reversible.
FOR HEALTH CARE PROFESSIONALS
Spirometry is the accepted standard for assessing whether airway obstruction is present, as well as for gauging its severity
Spirometric measurements that are required include the FEV1
, FVC and the ratio of these two values, the FEV1
Some spirometers provide measurement of the FEV6
as a surrogate for the FVC, in which case the FEV1
ratio is reported.
Most spirometers can report additional variables such as PEF (peak expiratory flow) and FEF25-75% but these are not required to make the diagnosis of airway obstruction.
All spirometers should meet or exceed the minimum requirements published by the American Thoracic Society and European Respiratory Society (ATS/ERS)
In addition to meeting the accuracy and precision guidelines of the ATS/ERS, spirometers should be easily configurable by the user to provide reports that include the patient’s FEV1
, FVC and FEV1
/FVC ratio (or FEV1
ratio if applicable).
In addition to the measured values, each spirometer should provide functionality to display the predicted value or predicted range to assist in identifying abnormal lung function, particularly airway obstruction.
The ATS/ERS guidelines recommend using the lower limit of normal (LLN based on the 95th percentile for healthy never-smokers) to establish a diagnosis of obstruction, so spirometers should provide these values as well
Spirometers for use in the U.S. should utilize the NHANES III reference equations
which include predicted and LLN values for the parameters noted above 3.
Additional reference equations for subjects 3-95 years of age of various ethnicities are available from the Global Lungs Initiative
Spirometers should be able to record pre- and post-bronchodilator spirometry, and display the % change after bronchodilator as part of the report.
Most spirometers require calibration for each day they are used; a 3 liter syringe is the standard device for calibration recommended by the ATS/ERS guidelines.
Some portable spirometers use disposable flow sensors which are calibrated at the time of manufacture.
A method of checking the accuracy of these types of spirometers is recommended by NLHEP.
Prior to 2009, NLHEP offered a formal spirometer review, but this program has been discontinued. Table 1 lists spirometers that achieved recommended status under the review program.
Table 1. Office Spirometers that Meet NLHEP Criteria
PERFORMANCE OF SPIROMETRY
Although spirometry is a relatively simple test to perform, it is largely dependent on patient effort. Acceptability and repeatability criteria have been published by the ATS/ERS2:
The patient must inhale maximally to total lung capacity, then blast the air out
There should be no cough or hesitation during the first second of the maximal exhalation
The patient must continue to exhale forcefully for at least 6 seconds and until a plateau is reached (3 seconds for children under age 10)
A minimum of three acceptable maneuvers is required
The largest and second largest FVC and FEV1 values should be repeatable within 150 ml (100 ml if the FVC is less than 1.00 L)
The largest FVC and FEV1 from acceptable efforts are reported; the FEV1/FVC is calculated from these values
Subjects who exhibit airway obstruction on spirometry, should have the measurements repeated following inhalation of a beta-adrenergic bronchodilator. Post-bronchodilator spirometry which returns to within normal limits suggests that the patient has reversible airway obstruction. If the FEV1 or FVC improves by at least 12% and 200 ml following inhaled bronchodilator, there is some element of reversible airway obstruction.
Screening to "rule out" significant airway obstruction combines a simple questionnaire with measurement of either FEV1
or PEF (peak expiratory flow)
Subjects with significant risk factors may perform a series of maximal expiratory effort to obtain FEV1
or PEF using a small portable device.
If the measured FEV1
or PEF is within normal limits for the subject's age, gender, height and ethnicity, airway obstruction is unlikely.
If the measured variables are NOT within normal limits or the subject is unable to perform the maneuvers acceptably, he/she should be referred for formal spirometry with pre- and post-bronchodilator measurements.
 GOLD Scientific Committee: GOLD Spirometry guide. Updated 2010.
 Miller MR, Hankinson J, Brusasco V, Burgos F, et al: Standardisation of spirometry. Eur Respir J 2005; 26: 319–338.
 Pellegrino R, Viegi G, Brusasco V, Crapo RO, et al: Interpretative strategies for lung function tests. Eur Respir J 2005; 26: 948–968.
 Quanjer PH, Stanojevic S, Cole T, Baur X, et al, on behalf of the ERS Global Lung Function Initiative. Multi-ethnic reference values for spirometry for the 3-95 year age range: the global lung function 2012 equations. Eur Respir J. 2012 Dec;40(6):1324-43.
 Nelson SB, LaVange LM, Nie Y, Walsh JW, et al: Questionnaires and pocket spirometers provide an alternative approach for COPD screening in the general population. Chest. 2012 Aug;142(2):358-66.
 Jithoo A, Enright PL, Burney P, Buist AS, et al: Case-finding options for COPD: Results from the BOLD Study. Eur Respir J. 2012 Jun 27. [Epub ahead of print]